ECHOSENS
Echosens , a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert, a high-performance elastography engine that implements newly developed spleen stiffness measurement (SSM by VCTE™) in FibroScan, a non-invasive biomarker that can be used to diagnose and monitor liver health and identified as a valuable diagnostic tool in assessing portal hypertension (PH). The Baveno VI guidelines recognize that elevated liver stiffness measurement by FibroScan can be an effective way to establish the risk of esophageal varices, a common manifestation of PH, increased blood pressure in the veins that enters the liver and is responsible for many of the manifestations of liver cirrhosis. The combination of SSM by VCTE™ in adjunction with Baveno VI criteria allows safely sparing endoscopy in more patients.
“Given the significant increase in potential cases of liver cirrhosis due to non-alcoholic steatohepatitis (NASH) and alcoholic liver disease, there is a critical need for the FibroScan 630 Expert as a cost effective, non-invasive modality for screening and management,” says Professor Massimo Pinzani, M.D., Ph.D., FRCP, Sheila Sherlock chair of hepatology, and director, University College London’s Institute for Liver and Digestive Health. “In cirrhotic patients, spleen stiffness correlates better with Hepatic Venous Pressure Gradient (HVPG ) and presence of high risk esophageal varices than liver stiffness.”
The FibroScan 630 Expert offers improved ergonomics, embedded ultrasound guidance system, intuitive user interface, touchscreen, advanced keyboard and an integrated barcode reader.
In Western countries, alcoholic and viral cirrhosis are the leading causes of PH and esophageal varices, with 30% of patients with compensated cirrhosis and 60-70% of patients with decompensated cirrhosis having gastroesophageal varices at the time of diagnosis. The frequency of gastroesophageal varices directly correlates with the severity of the liver disease from 40% in class A (low risk) to 85% in class C (high risk) in cirrhotic patients.
Laurent Sandrin, chairman and co-founder of Echosens, says, “As liver disease has become an epidemic worldwide, FibroScan 630 Expert serves as an important, non-invasive and cost-effective tool for assessing its severity and prognosis. A dedicated SSM by VCTE™ exam based on a 100 Hz shear wave frequency has been developed to comply with the more elevated stiffness of spleen compared to liver. With liver stiffness measurement (LSM by VCTE™), CAP™ and SSM by VCTE™ as surrogate markers of liver fibrosis, liver steatosis and portal hypertension respectively, the FibroScan 630 provides a comprehensive solution to manage patients with chronic liver diseases including advanced liver disease.”
About Echosens
Echosens is the world’s number one provider of non-invasive medical devices dedicated to assessment of chronic liver diseases.
Echosens pioneered the field of elastography technology by developing FibroScan®, the first device that quantifies liver stiffness non-invasively.
Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ for liver fibrosis assessment, and CAP™ for steatosis quantification.
FibroScan® device is recognized worldwide as the reference for non-invasive liver diagnosis with more than 2,000 medical publications and 40 guidelines recommendations.
With a wide-reaching international distribution network, including Europe, spanning France (Paris), Germany, Spain and the United Kingdom, as well as the United States (Waltham) and China (Shanghai, Shenzhen and Beijing), Echosens has made FibroScan® available in over 80 countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200304005612/en/
Link:
Social Media:
https://www.facebook.com/EchosensNorthAmerica/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Université Paris-Saclay and Owkin: A Unique Alliance to Propel University Medical Research to the Top of the European Rankings Through AI20.11.2025 15:17:00 CET | Press release
Université Paris-Saclay and Owkin announce the signing of a memorandum of understanding to explore the potential of K Pro Free - Owkin’s AI co-pilot for biology - for use by Paris-Saclay. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120130113/en/ K Pro Free will now be available to the entire Université Paris-Saclay community, and in particular teachers, researchers and doctoral students working in the biomedical sciences. The partnership includes workshops, training sessions and events designed to promote the discovery and adoption of K Pro Free, as well as the co-organization of communication and dissemination initiatives around the use of AI in health. In this way, the partnership will promote user training, but also enrich and continuously improve the co-pilot's models through feedback and use cases from the l’Université Paris-Saclay community. This partnership is part of Université Paris-Saclay’s strategy to integr
Frasca Advances Flight Training Technology with New Visual System Powered by Unreal Engine20.11.2025 15:05:00 CET | Press release
Frasca International, Inc., a FlightSafety International company and leader in flight simulation, today announced the launch of VITAL FVS 100, the next evolution of its visual system technology. Building on the proven TruVision Global platform, VITAL FVS 100 was developed using Epic Games’ Unreal Engine and delivers unprecedented realism, scalability, and innovation in pilot training. The Unreal-powered VITAL FVS 100 system introduces major advancements in visual fidelity and training realism, further enhancing the capabilities of Frasca, a leading developer of flight simulators and training devices. The new system includes physically based renderings, advanced lighting effects, and a new volumetric cloud model that creates dynamic, weather-rich environments. Terrain imagery now includes one-meter resolution coverage for the contiguous United States and Hawaii, with expanded global datasets covering European buildings and tree covered regions. Additionally, enhanced particle effects re
GigaOm Radar for Vector Databases v3 Positions Vespa.ai as a Leader and Outperformer20.11.2025 15:00:00 CET | Press release
Vespa Recognized for Integrated Ranking, Multimodal Search, and Production-Scale AI Performance Vespa.ai, the creator of the AI Search Platform for building and deploying large-scale, real-time AI applications powered by big data, today announced its recognition as a Leader and Outperformer in the GigaOm Radar for Vector Databases v3, marking the company’s third consecutive year being evaluated in GigaOm’s vector database research. Now in its third edition, the report compares 17 leading open source and commercial solutions using GigaOm’s structured evaluation framework. In addition to core table-stakes capabilities, the Radar reviews each vendor’s key features, emerging strengths, and broader business criteria. The shift from Sonar to Radar reflects the technology’s transition into mainstream adoption. GigaOm names Vespa.ai a leader for its ability to manage complex data, optimize results at scale, and support multimodal AI workloads. The report highlights Vespa’s native tensor suppor
Hitit Empowers Airlines to Optimize Crew Leave Planning with Gurobi20.11.2025 15:00:00 CET | Press release
With Crane Crew, one of the products in Hitit’s Crane Solution Suite, dozens of airlines have reduced their planning periods from weeks to minutes. Gurobi Optimization, LLC, the leader in decision intelligence technology, is proud to be the solver of choice for Hitit, a leading global provider of airline and travel IT solutions. Hitit’s Crane Crew Leave Optimizer—one of the key sub-modules of Hitit’s Crane Crew solution—enables airlines to quickly generate optimal leave schedules for thousands of crew members. Powered by Gurobi’s mathematical optimization solver, the tool significantly reduces planning time while improving both operational efficiency and crew satisfaction. Among the many constraints that airlines must consider are operational requirements, business rules, crew seniority, and personal preferences. As such, manual planning efforts can often lead to inefficiencies, crew dissatisfaction, and compliance risks. After switching to Crane Crew, Hitit’s partner airlines have rep
Myonex Appoints Greg Lavin as Chief Executive Officer20.11.2025 15:00:00 CET | Press release
Greg Lavin takes over the CEO role as James Lovett retires and joins the company’s Board of Directors Myonex®, a leading global integrated clinical trial supply solutions and commercial services company, announced today that Greg Lavin, Chief Financial Officer (CFO), will assume the role of Chief Executive Officer (CEO) effective January 1, 2026. A seasoned executive with experience in the pharmaceutical services industry, including senior roles across clinical research organizations, preclinical and laboratory services, and healthcare data analysis, Lavin succeeds James Lovett, who is retiring and will remain on the company’s board of directors to provide strategic guidance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251120250133/en/ Greg Lavin at Myonex's Headquarters in Horsham, PA During his 6-plus years as CFO of Myonex, Lavin has worked closely with Lovett in driving its transformation from a comparator sourcing su
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom